BRR OpCo’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,856
Closed -$477K 222
2021
Q4
$477K Sell
1,856
-945
-34% -$231K 0.05% 133
2021
Q3
$680K Buy
+2,801
New +$685K 0.08% 118
2019
Q4
Sell
-8,451
Closed -$1.02M 188
2019
Q3
$1.02M Buy
8,451
+741
+10% +$95.8K 0.16% 56
2019
Q2
$1.04M Buy
7,710
+5,660
+276% +$716K 0.17% 55
2019
Q1
$267K Buy
+2,050
New +$275K 0.05% 132
2016
Q4
Sell
-3,281
Closed -$248K 99
2016
Q3
$248K Hold
3,281
0.08% 95
2016
Q2
$253K Sell
3,281
-448
-12% -$35.4K 0.08% 93
2016
Q1
$291K Buy
+3,729
New +$260K 0.1% 83
2015
Q3
Sell
-2,276
Closed -$206K 100
2015
Q2
$206K Sell
2,276
-957
-30% -$76.7K 0.08% 99
2015
Q1
$243K Buy
+3,233
New +$232K 0.1% 87

Other funds holding HCA

BRR OpCo's HCA Position: Q1 2022 in Review

BRR OpCo sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 1,856 shares — an estimated $477K sold.

BRR OpCo first reported a position in HCA in Q1 2015 and held it in 10 quarters. The position peaked at $1.04M in Q2 2019. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

  • BRR OpCo reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
  • BRR OpCo sold 1,856 HCA Healthcare shares in Q1 2022, an estimated $477K.
  • BRR OpCo first reported a position in HCA Healthcare in Q1 2015 and held it in 10 quarters.
  • BRR OpCo's HCA Healthcare position peaked at $1.04M in Q2 2019.
  • 968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on BRR OpCo's 13F filing for Q1 2022, filed 5 May 2022.